Category: <span>International Mesothelioma Interest Group</span>

FDA Fast Tracks New Pleural Mesothelioma Drug

The U.S. Food & Drug Administration (FDA) has decided to fast track SELLAS™ Life Sciences’ new drug Galinpepimut-S to treat pleural mesothelioma

Research Team to Give Exciting Presentations at Mesothelioma Conference in South Africa

Drug Developer to Present New Data at Annual Mesothelioma Conference

Mesothelioma Study Identifies Four Biomarkers That May Help Speed Up Diagnoses and Treatment

Scientists Identify Four Biomarkers That May Improve Mesothelioma Diagnostics